Rare variants in complement system genes associate with endothelial damage after pediatric allogeneic hematopoietic stem cell transplantation.
acute toxicity
complement system
endothelial damage
hematopoietic stem cell transplantation
hematopoietic stem cell transplantation adverse effects
vascular complications
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
29
06
2023
accepted:
29
08
2023
medline:
4
10
2023
pubmed:
29
9
2023
entrez:
29
9
2023
Statut:
epublish
Résumé
Complement system has a postulated role in endothelial problems after hematopoietic stem cell transplantation (HSCT). In this retrospective, singlecenter study we studied genetic complement system variants in patients with documented endotheliopathy. In our previous study among pediatric patients with an allogeneic HSCT (2001-2013) at the Helsinki University Children´s Hospital, Finland, we identified a total of 19/122 (15.6%) patients with vascular complications, fulfilling the criteria of capillary leak syndrome (CLS), venoocclusive disease/sinusoidal obstruction syndrome (VOD/SOS) or thrombotic microangiopathy (TMA). We performed whole exome sequencing (WES) on 109 patients having an adequate pre-transplantation DNA for the analysis to define possible variations and mutations potentially predisposing to functional abnormalities of the complement system. In our data analysis, we focused on 41 genes coding for complement components. 50 patients (45.9%) had one or several, nonsynonymous, rare germline variants in complement genes. 21/66 (31.8%) of the variants were in the terminal pathway. Patients with endotheliopathy had variants in different complement genes: in the terminal pathway (C6 and C9), lectin pathway (MASP1) and receptor ITGAM (CD11b, part of CR3). Four had the same rare missense variant (rs183125896; Thr279Ala) in the C9 gene. Two of these patients were diagnosed with endotheliopathy and one with capillary leak syndrome-like problems. The C9 variant Thr279Ala has no previously known disease associations and is classified by the ACMG guidelines as a variant of uncertain significance (VUS). We conducted a gene burden test with gnomAD Finnish (fin) as the reference population. Complement gene variants seen in our patient population were investigated and Total Frequency Testing (TFT) was used for execution of burden tests. The gene variants seen in our patients with endotheliopathy were all significantly (FDR < 0.05) enriched compared to gnomAD. Overall, 14/25 genes coding for components of the complement system had an increased burden of missense variants among the patients when compared to the gnomAD Finnish population (N=10 816). Injury to the vascular endothelium is relatively common after HSCT with different phenotypic appearances suggesting yet unidentified underlying mechanisms. Variants in complement components may be related to endotheliopathy and poor prognosis in these patients.
Identifiants
pubmed: 37771589
doi: 10.3389/fimmu.2023.1249958
pmc: PMC10525714
doi:
Substances chimiques
Complement System Proteins
9007-36-7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1249958Informations de copyright
Copyright © 2023 Leimi, Koski, Kilpivaara, Vettenranta, Lokki and Meri.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Front Med (Lausanne). 2018 Mar 15;5:52
pubmed: 29600248
J Immunol. 2010 Nov 1;185(9):5628-36
pubmed: 20870944
Exp Neurol. 2021 Jun;340:113654
pubmed: 33617886
Nucleic Acids Res. 2020 Jan 8;48(D1):D835-D844
pubmed: 31777943
Brain Behav. 2020 Aug;10(8):e01728
pubmed: 32564512
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Bone Marrow Transplant. 2022 May;57(5):705-711
pubmed: 35177827
BJOG. 2021 Jul;128(8):1282-1291
pubmed: 33539617
Blood. 2016 Mar 31;127(13):1719-27
pubmed: 26755708
Blood Adv. 2021 Jan 12;5(1):1-11
pubmed: 33570619
Retin Cases Brief Rep. 2023 Mar 1;17(2):154-159
pubmed: 33492076
Biol Blood Marrow Transplant. 2013 Dec;19(12):1683-9
pubmed: 24055655
BMC Nephrol. 2021 Jul 6;22(1):252
pubmed: 34229609
Front Oncol. 2021 Nov 08;11:772411
pubmed: 34820335
Int J Mol Sci. 2022 Mar 09;23(6):
pubmed: 35328364
Bone Marrow Transplant. 2021 Oct;56(10):2326-2335
pubmed: 34253879
Front Oncol. 2021 Oct 13;11:755878
pubmed: 34722309
Chest. 2022 Aug;162(2):346-355
pubmed: 35413279
PLoS One. 2012;7(4):e35690
pubmed: 22536427
Nat Commun. 2022 Apr 12;13(1):1955
pubmed: 35413960
Blood. 2016 Feb 25;127(8):989-96
pubmed: 26603840
Bone Marrow Transplant. 2011 Dec;46(12):1495-502
pubmed: 21460864
Bone Marrow Transplant. 2016 Feb;51(2):267-72
pubmed: 26642337
Pediatr Blood Cancer. 2013 Sep;60(9):1520-7
pubmed: 23733511
Blood Adv. 2019 Aug 13;3(15):2424-2435
pubmed: 31409584
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
J Pers Med. 2021 May 25;11(6):
pubmed: 34070379
J Immunol. 2022 Jun 15;208(12):2597-2612
pubmed: 35867677
Clin Chim Acta. 2019 Jul;494:143-150
pubmed: 30905589
Am J Hum Genet. 2017 Feb 2;100(2):267-280
pubmed: 28132688
Pediatr Nephrol. 2019 Mar;34(3):379-388
pubmed: 29214442
Nature. 2023 Jan;613(7944):508-518
pubmed: 36653562
Blood. 2017 Sep 7;130(10):1259-1266
pubmed: 28705839
Front Immunol. 2019 Feb 27;10:337
pubmed: 30891033
Sci Rep. 2022 Jun 23;12(1):10670
pubmed: 35739278
Semin Hematol. 2018 Jul;55(3):159-166
pubmed: 30032753
Am J Respir Crit Care Med. 2019 Jan 15;199(2):181-189
pubmed: 30114376
J Thromb Haemost. 2015 Jun;13 Suppl 1:S121-32
pubmed: 26149013
Blood Rev. 2015 May;29(3):191-204
pubmed: 25483393
Intensive Care Med. 2016 Jul;42(7):1137-45
pubmed: 27101828
Bone Marrow Transplant. 2021 Aug;56(8):1805-1817
pubmed: 33875812
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Nat Protoc. 2018 Nov;13(11):2580-2600
pubmed: 30323186
Am J Physiol Lung Cell Mol Physiol. 2016 Feb 1;310(3):L224-31
pubmed: 26660787
Front Immunol. 2021 Jul 05;12:714511
pubmed: 34290717
Front Pediatr. 2019 Apr 09;7:133
pubmed: 31024873
Bone Marrow Transplant. 2018 Feb;53(2):129-137
pubmed: 28967899
Nat Commun. 2016 Feb 04;7:10588
pubmed: 26841934
Front Immunol. 2019 Mar 14;10:449
pubmed: 30923524
Genet Epidemiol. 2011 Nov;35(7):606-19
pubmed: 21769936
Adv Ther. 2022 Sep;39(9):3896-3915
pubmed: 35781192
J Clin Oncol. 2022 Aug 1;40(22):2447-2457
pubmed: 35439028
Thromb Res. 2020 Oct;194:36-41
pubmed: 32569879